Bellevue Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$24.5K | – | 161 |
|
|
2023
Q2 | $24.5K | Hold |
1,000
| – | – | ﹤0.01% | 154 |
|
|
2023
Q1 | $31.3K | Sell |
1,000
-302,100
| -100% | -$9.46M | ﹤0.01% | 155 |
|
|
2022
Q4 | $21.3M | Hold |
303,100
| – | – | 0.28% | 81 |
|
|
2022
Q3 | $26.1M | Sell |
303,100
-400
| -0.1% | -$34.4K | 0.37% | 70 |
|
|
2022
Q2 | $25.1M | Sell |
303,500
-163,315
| -35% | -$13.5M | 0.35% | 76 |
|
|
2022
Q1 | $77.6M | Sell |
466,815
-25,000
| -5% | -$4.16M | 0.9% | 40 |
|
|
2021
Q4 | $82.2M | Buy |
491,815
+38,500
| +8% | +$6.44M | 0.85% | 38 |
|
|
2021
Q3 | $39.2M | Hold |
453,315
| – | – | 0.4% | 79 |
|
|
2021
Q2 | $24.6M | Hold |
453,315
| – | – | 0.24% | 100 |
|
|
2021
Q1 | $27M | Hold |
453,315
| – | – | 0.29% | 93 |
|
|
2020
Q4 | $23.7M | Hold |
453,315
| – | – | 0.27% | 91 |
|
|
2020
Q3 | $21.9M | Buy |
453,315
+29,121
| +7% | +$1.41M | 0.3% | 85 |
|
|
2020
Q2 | $22M | Buy |
424,194
+72,305
| +21% | +$3.75M | 0.31% | 75 |
|
|
2020
Q1 | $15.3M | Buy |
351,889
+196,822
| +127% | +$8.58M | 0.3% | 68 |
|
|
2019
Q4 | $6.22M | Buy |
155,067
+32,015
| +26% | +$1.28M | 0.1% | 108 |
|
|
2019
Q3 | $4.04M | Hold |
123,052
| – | – | 0.08% | 117 |
|
|
2019
Q2 | $9.49M | Buy |
+123,052
| New | +$9.49M | 0.16% | 89 |
|